Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

Q2 2015

IBB Guru Trades in Q2 2015

George Soros 2,400 sh (New)
John Keeley 905 sh (unchged)
» More
Q3 2015

IBB Guru Trades in Q3 2015

George Soros Sold Out
John Keeley Sold Out
» More
Q4 2015

IBB Guru Trades in Q4 2015

Louis Moore Bacon 36,421 sh (New)
Steven Cohen 5,000 sh (New)
» More
Q1 2016

IBB Guru Trades in Q1 2016

George Soros 67,600 sh (New)
Steven Cohen Sold Out
Louis Moore Bacon Sold Out
» More

Ratios

vs
industry
vs
history
P/E(ttm) 19.71
IBB's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 19.71 )
Ranked among companies with meaningful P/E(ttm) only.
IBB' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 19.71
Current: 19.71
0
19.71
PE(NRI) 19.71
IBB's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 19.71 )
Ranked among companies with meaningful PE(NRI) only.
IBB' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 19.71
Current: 19.71
0
19.71
P/B 4.77
IBB's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 4.77 )
Ranked among companies with meaningful P/B only.
IBB' s P/B Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 4.77
Current: 4.77
0
4.77

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.12
IBB's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 0.12 )
Ranked among companies with meaningful Dividend Yield only.
IBB' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0.12
Current: 0.12
0
0.12
Yield on cost (5-Year) 0.12
IBB's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 0.12 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
IBB' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0.12
Current: 0.12
0
0.12

More Statistics

Short Percentage of Float0.00%
52-Week Range $241.49 - 386.68
Shares Outstanding (Mil)25,650,000.00
» More Articles for IBB

Headlines

Articles On GuruFocus.com
A Quart of Milk, a Loaf of Bread and 22% ROE at Casey's General Stores Jul 27 2016 
Gilead Sciences Is Still a Buy Jul 27 2016 
Irish Brewer Could Be a Buyout Candidate Jul 27 2016 
How Walmart Can Fight Online Encroachment Jul 27 2016 
Key Metrics: Price to Sales Jul 27 2016 
Paul Jacobson Buys Delta Jul 27 2016 
Barrick Is Positioned to Meet Expectations Jul 27 2016 
Gilead’s Valuation Makes It a Screaming Buy Jul 27 2016 
Mario Gabelli Comments on Viacom Inc. Jul 27 2016 
Mario Gabelli Comments on Sony Corp Jul 27 2016 

More From Other Websites
A breakthrough for biotech? Jul 27 2016
9:53 am iShares Nasdaq Biotech ETF displaying early relative strength Jul 27 2016
Yee: Biotech stocks will outperform after election Jul 25 2016
Bracing for a 'bio-wreck'? Jul 25 2016
Gilead Sciences: Expect an Earnings Beat? Jul 25 2016
This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles Jul 25 2016
Stock Market Video - Uptrend Continues.. Jul 22 2016
Biogen: Prelude to a Sale? Jul 22 2016
The Zacks Analyst Blog Highlights: UnitedHealth, Humana, Aetna, Universal Health and iShares NASDAQ... Jul 22 2016
Here's How Presidents and Elections Affect the Stock Market Jul 21 2016
Is biotech back? Jul 21 2016
This indicator says the stock market’s latest funfest has gone too far Jul 20 2016
Biotech ETFs are at a Crucial Technical Juncture Jul 18 2016
Did Shkreli kill the biotech rally? Jul 14 2016
Investors chasing dividends around the world Jul 13 2016
Biotech ETFs: Will the Once Hot Group Rebound? Jul 13 2016
Nasdaq on pace for 8th straight day of gains Jul 11 2016
Silence the Noise: Illumina Revenue Is Trending Higher Jul 10 2016
52 Week High for S&P 500 Jul 08 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK